Clinical Trial Update: Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures [NA]

View source ↗

Summary

Clinical trial update reports termination of the BioTraceIO 360 study for planning, monitoring, and assessment of liver tissue ablation procedures in hepatocell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma
• Liver Cancer

Snippet

Sponsor: Techsomed Medical Technologies LTD | Conditions: Hepatocellular Carcinoma, Metastatic Liver Cancer | NA | Status: TERMINATED